Evolus signs option deal with private partner for sustained — release injectable hair restoration program
Evolus entered an option agreement with a privately held developer of a sustained-release injectable hair restoration treatment. Initial option payment totals $1.5 million, with additional stage-gated payments tied to development milestones. Evolus will support development work, including an initial clinical proof-of-c